We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Modified-Release Nifedipine: A Review of the Use of Modified-Release Formulations in the Treatment of Hypertension and Angina Pectoris.
- Authors
Croom, Katherine F.; Wellington, Keri
- Abstract
Nifedipine is a dihydropyridine calcium channel antagonist with predominantly vasodilatory activity. Modified-release formulations of nifedipine are effective antihypertensive and antianginal therapies and are generally well tolerated. Among the available formulations, those that produce a gradual increase in plasma nifedipine concentration, which is then sustained over a 24-hour period, are preferred, as they cause a gradual onset of vasodilatation and avoid baroreflex sympathetic activation (for example, nifedipine gastrointestinal therapeutic system [GITS] and a Japanese controlled-release formulation). Modified-release nifedipine had beneficial effects on a number of markers of vascular function, and nifedipine GITS reduced the need for coronary procedures in patients with coronary artery disease. In patients with hypertension, nifedipine GITS and nifedipine retard had beneficial effects on the overall incidence of major cardiovascular events, as did nifedipine retard in patients with concurrent hypertension and coronary artery disease.
- Subjects
NIFEDIPINE; DIHYDROPYRIDINE; ANGINA pectoris treatment; HYPERTENSION; CALCIUM antagonists; THERAPEUTICS; VASODILATION; BAROREFLEXES; CORONARY arteries
- Publication
Drugs, 2006, Vol 66, Issue 4, p497
- ISSN
0012-6667
- Publication type
Article
- DOI
10.2165/00003495-200666040-00007